menu
    • menu

    Company profile for Onchilles Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Onchilles Pharma was founded on breakthrough research that was the first to describe that human neutrophils release a major anticancer protein, called ELANE, that broadly and selectively activates cell death pathways in cancer cells. This fundamental pathway of the innate immune system has the potential for universal anti-cancer activity, independent of genetic mutation. Based on this research, Onchilles is developing a pipeli...
    Onchilles Pharma was founded on breakthrough research that was the first to describe that human neutrophils release a major anticancer protein, called ELANE, that broadly and selectively activates cell death pathways in cancer cells. This fundamental pathway of the innate immune system has the potential for universal anti-cancer activity, independent of genetic mutation. Based on this research, Onchilles is developing a pipeline of first-in-class biologic drug candidates with the potential to be broadly effective against a wide range of cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Onchilles PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9880 Campus Point Drive, Suite 420 San Diego, California 92121
    Telephone
    Telephone
    (202) 256-4334
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://onchillespharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/onchillespharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/onchilles

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onchilles Publishes ELANE Pathway Study And Advances N17350
    Onchilles Publishes ELANE Pathway Study And Advances N17350

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107100720/en/Onchilles-Pharma-Publishes-Landmark-ELANE-Pathway-Study-and-Advances-N17350-Toward-the-Clinic-With-New-Financing-and-Leading-Clinical-Advisor

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Onchilles Pharma Presents New Data at AACR 2025 on N17350
    Onchilles Pharma Presents New Data at AACR 2025 on N17350

    25 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250425701875/en/Onchilles-Pharma-Presents-New-Data-at-AACR-2025-Highlighting-N17350-a-Next-Generation-Cytotoxic-Therapeutic-Leveraging-the-ELANE-Pathway

    BUSINESSWIRE
    25 Apr 2025
    Share Share
    Onchilles Advances ELANE Pathway Pan-Cancer Therapeutics
    Onchilles Advances ELANE Pathway Pan-Cancer Therapeutics

    13 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250113083088/en

    BUSINESSWIRE
    13 Jan 2025
    Share Share
    Onchilles Pharma Presents Data on NEU-002 for ELANE Pathway at SITC
    Onchilles Pharma Presents Data on NEU-002 for ELANE Pathway at SITC

    07 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241107381437/en

    BUSINESSWIRE
    07 Nov 2024
    Share Share
    Onchilles Pharma To Present NEU-002 Program Data At SITC 2024
    Onchilles Pharma To Present NEU-002 Program Data At SITC 2024

    04 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241004797658/en

    BUSINESSWIRE
    04 Oct 2024
    Share Share
    Onchilles Pharma Presents N17350, N17465 Preclinical Data at AACR 2024
    Onchilles Pharma Presents N17350, N17465 Preclinical Data at AACR 2024

    10 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240409001249/en

    BUSINESSWIRE
    10 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search